Dr Steven Douglas Barney, DDS | |
6979 South Holly Circle, Suite 105, Centennial, CO 80112 | |
(720) 638-3888 | |
(720) 638-3887 |
Full Name | Dr Steven Douglas Barney |
---|---|
Gender | Male |
Speciality | Oral & Maxillofacial Surgery |
Location | 6979 South Holly Circle, Centennial, Colorado |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1083675888 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1223P0106X | Dentist - Oral And Maxillofacial Pathology | 40207 (California) | Secondary |
204E00000X | Oral & Maxillofacial Surgery | 201794 (Colorado) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Steven Douglas Barney, DDS 6834 S. University Blvd., #134, Centennial, CO 80122 Ph: (310) 377-0929 | Dr Steven Douglas Barney, DDS 6979 South Holly Circle, Suite 105, Centennial, CO 80112 Ph: (720) 638-3888 |
News Archive
Researchers from Davos Life Science in Singapore, in collaboration with scientists at the University of Hong Kong, have shown that gamma-tocotrienol, a member of the vitamin E family, is potent in killing prostate tumour cells in animal model studies. This research was reported this week in the latest edition of Pharmacology.
Orabrush, the tongue cleaner that helps cure bad breath, today announced that the company has closed a $2.5 million investment round with True Ventures of Palo Alto and returning investor 2x Consumer Products Growth Partners of Chicago. Funds will be used to help further accelerate the company's retail growth by maximizing its exceptional online brand and expanding its retail partnerships and distribution channels throughout the world.
Researchers from UCLA's Jonsson Comprehensive Cancer Center have identified a cell-permeable peptide that inhibits a hepatitis C virus protein and blocks viral replication, which can lead to liver cancer and cirrhosis.
AGA Medical Holdings, Inc. (AGA Medical) today announced the completion of the first phase of a litigation between AGA Medical and Medtronic, Inc., in which a California jury returned a verdict that some of AGA Medical's products infringed some of the claims of patents held by Medtronic, and that these patents have not been proven invalid over prior art.
PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced that it has agreed to purchase the remaining interest of its joint venture in Inductively Coupled Plasma Mass Spectrometry (ICP-MS) and related assets from Danaher Corporation. Danaher acquired this joint venture stake and these assets as part of its acquisition of MDS Inc.'s Analytical Technologies business.
› Verified 5 days ago